This report provides comprehensive information on the current therapeutic developmental pipeline of Quantum Genomics SAs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. http://www.researchmoz.us/quantum-genomics-sa-product-pipeline-review-2015-report.html

1. Quantum Genomics SA - Product Pipeline Review - 2015
Global Markets Directs, Quantum Genomics SA Product Pipeline Review 2015, provides an overview of the Quantum Genomics SAs pharmaceutical research
and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Quantum Genomics SAs, complete with comparative
analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews
latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides brief overview of Quantum Genomics SA including business description, key information and facts, and its locations and subsidiaries The
report reviews current pipeline of Quantum Genomics SAs human therapeutic division and enlists all their major and minor projects The report features product
description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature
on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news
and deals relating to the Quantum Genomics SAs pipeline products
Reasons to buy
Evaluate Quantum Genomics SAs strategic position with total access to detailed information on its product pipeline Assess the growth potential of Quantum
Genomics SA in its therapy areas of focus Identify new drug targets and therapeutic classes in the Quantum Genomics SAs R&D portfolio and develop key
strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop
strategic initiatives by understanding the focus areas of Quantum Genomics SA and exploit collaboration and partnership opportunities Identify emerging players
with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions effectively by
identifying the most promising pipeline of Quantum Genomics SA Develop and design in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of Quantum
Genomics SA and identify potential opportunities in those areas Avoid Intellectual Property Rights related issues
table Of Contents
table Of Contents 2
list Of Tables 3
list Of Figures 3
quantum Genomics Sa Snapshot 4
quantum Genomics Sa Overview 4
key Information 4
key Facts 4
quantum Genomics Sa - Research And Development Overview 5
key Therapeutic Areas 5
quantum Genomics Sa - Pipeline Review 7
pipeline Products By Stage Of Development 7
pipeline Products - Monotherapy 8
quantum Genomics Sa - Pipeline Products Glance 9
quantum Genomics Sa - Clinical Stage Pipeline Products 9
phase Ii Products/combination Treatment Modalities 9
quantum Genomics Sa - Early Stage Pipeline Products 10
preclinical Products/combination Treatment Modalities 10
discovery Products/combination Treatment Modalities 11
quantum Genomics Sa - Drug Profiles 12
qgc-001 12
product Description 12
mechanism Of Action 12
r&d Progress 12
qgc-011 14
product Description 14
mechanism Of Action 14
r&d Progress 14
qgc-101 15
product Description 15
mechanism Of Action 15
r&d Progress 15
Quantum Genomics SA - Product Pipeline Review - 2015

2. qgc-006 16
product Description 16
mechanism Of Action 16
r&d Progress 16
quantum Genomics Sa - Pipeline Analysis 17
quantum Genomics Sa - Pipeline Products By Route Of Administration 17
quantum Genomics Sa - Pipeline Products By Molecule Type 18
quantum Genomics Sa - Recent Pipeline Updates 19
quantum Genomics Sa - Dormant Projects 20
quantum Genomics Sa - Locations And Subsidiaries 21
head Office 21
appendix 22
methodology 22
coverage 22
secondary Research 22
primary Research 22
expert Panel Validation 22
contact Us 22
disclaimer 23
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Quantum Genomics SA - Product Pipeline Review - 2015